G81845KC
| Organisms | Evidence |
|---|---|
| Pseudomonas | |
| Burkholderia cepacia complex | |
| Burkholderia cepacia |
RES 1r:r1 REP REP1:6o(5+1)2d=-1--1 RES 2b:b-dgal-HEX-1:5 3b:a-dgal-HEX-1:5 4b:b-dgal-HEX-1:5 5s:acetyl 6b:b-dman-OCT-2:6|1:a|2:keto|3:d LIN 1:2o(3+1)3d 2:3o(4+1)4d 3:4o(2+1)5n 4:4o(3+2)6d
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 16860003 | Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex | Herasimenka Y | 2007 Apr |
|
| 14670727 | Exopolysaccharides produced by a clinical strain of Burkholderia cepacia isolated from a cystic fibrosis patient | Cescutti P | 2003 Nov 14 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025